[{"Assets_0_Q2_USD":137058000.0,"CommonStockSharesOutstanding_0_Q2_shares":131888000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-33270000.0,"NetIncomeLoss_1_Q2_USD":-22540000.0,"NetIncomeLoss_2_Q2_USD":-46719000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":21578000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":40940000.0,"StockholdersEquity_0_Q2_USD":85474000.0,"Ticker":"PACB","CIK":"1299130","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","OfficialName":"Pacific Biosciences of California Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1643385656.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180803"}]